Patent · US Active

Process for preparing ibrutinib

US10214532B2 · kind B2 · utility

0Cited by

1References

15Claims

0Family size

Assignees

Shanghai Dude Medical Science and Technology Co., Ltd. · CN
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · CN
LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. · CN

Inventors

Xiquan Zhang · 安丰镇, CN
Rui Kong · Bethesda, US
Xin Liu · Hubei, CN
Shan Chen · Wuxi, CN
Xiaoping Chen · Austin, US
Leilei Yang · Lianyungang, CN
Aiming Zhang · Lianyungang, CN
Xingdong Cheng · Lianyungang, CN

Key dates

Filing date	Feb 4, 2016
Grant date	Feb 26, 2019
Priority date	—
Expiry date	Feb 4, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02P20/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to a method for preparing Ibutinib as shown by the following synthetic route and the intermediate compounds involved therein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.